The Netherlands Cancer Institute

This large, late-stage trial aims to see if adding the drug pembrolizumab to standard follow-up treatment helps prevent cancer from coming back in people with early triple-negative breast cancer. It will enroll 1,000 patients whose cancer did not completely disappear after initia…

This study is testing whether a special PET scan using a radioactive tracer can show how much of the tracer collects in lung cancer tumors with HER2 abnormalities. Researchers want to see if tumors with HER2 mutations collect the tracer differently than tumors that just have high…